Susquehanna International Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-19,500
| Closed | -$822K | – | 13342 |
|
|
2023
Q2 | $822K | Buy |
19,500
+12,300
| +171% | +$497K | ﹤0.01% | 7136 |
|
|
2023
Q1 | $256K | Buy |
7,200
+800
| +13% | +$29K | ﹤0.01% | 10061 |
|
|
2022
Q4 | $235K | Sell |
6,400
-10,700
| -63% | -$423K | ﹤0.01% | 9726 |
|
|
2022
Q3 | $806K | Sell |
17,100
-2,900
| -15% | -$187K | ﹤0.01% | 7199 |
|
|
2022
Q2 | $1.43M | Buy |
20,000
+5,200
| +35% | +$380K | ﹤0.01% | 5658 |
|
|
2022
Q1 | $1.2M | Sell |
14,800
-15,800
| -52% | -$1.34M | ﹤0.01% | 6661 |
|
|
2021
Q4 | $3.14M | Sell |
30,600
-5,100
| -14% | -$490K | ﹤0.01% | 4566 |
|
|
2021
Q3 | $3.12M | Sell |
35,700
-32,600
| -48% | -$2.95M | ﹤0.01% | 4870 |
|
|
2021
Q2 | $6.11M | Buy |
68,300
+11,600
| +20% | +$980K | ﹤0.01% | 3652 |
|
|
2021
Q1 | $4.3M | Buy |
56,700
+27,800
| +96% | +$2.1M | ﹤0.01% | 4206 |
|
|
2020
Q4 | $1.97M | Sell |
28,900
-10,700
| -27% | -$667K | ﹤0.01% | 5133 |
|
|
2020
Q3 | $2.1M | Sell |
39,600
-16,100
| -29% | -$959K | ﹤0.01% | 4519 |
|
|
2020
Q2 | $3.25M | Buy |
55,700
+200
| +0.4% | +$10.7K | ﹤0.01% | 3667 |
|
|
2020
Q1 | $2.19M | Sell |
55,500
-4,500
| -8% | -$263K | ﹤0.01% | 3811 |
|
|
2019
Q4 | $3.57M | Buy |
60,000
+33,800
| +129% | +$1.82M | ﹤0.01% | 3441 |
|
|
2019
Q3 | $1.39M | Buy |
26,200
+6,200
| +31% | +$318K | ﹤0.01% | 4984 |
|
|
2019
Q2 | $1.02M | Sell |
20,000
-81,800
| -80% | -$3.81M | ﹤0.01% | 5611 |
|
|
2019
Q1 | $5.27M | Buy |
101,800
+80,300
| +373% | +$3.89M | ﹤0.01% | 2385 |
|
|
2018
Q4 | $846K | Sell |
21,500
-29,300
| -58% | -$1.36M | ﹤0.01% | 5013 |
|
|
2018
Q3 | $2.62M | Sell |
50,800
-68,200
| -57% | -$3.34M | ﹤0.01% | 3574 |
|
|
2018
Q2 | $5.58M | Buy |
+119,000
| New | +$4.93M | ﹤0.01% | 2578 |
|
|
2018
Q1 | – | Sell |
-23,100
| Closed | -$1.01M | – | 10408 |
|
|
2017
Q4 | $1.01M | Sell |
23,100
-10,200
| -31% | -$477K | ﹤0.01% | 5217 |
|
|
2017
Q3 | $1.74M | Sell |
33,300
-22,400
| -40% | -$1.25M | ﹤0.01% | 4165 |
|
|
2017
Q2 | $3.26M | Buy |
55,700
+15,500
| +39% | +$805K | ﹤0.01% | 3018 |
|
|
2017
Q1 | $1.84M | Sell |
40,200
-5,800
| -13% | -$289K | ﹤0.01% | 3889 |
|
|
2016
Q4 | $2.42M | Buy |
46,000
+100
| +0.2% | +$4.84K | ﹤0.01% | 3664 |
|
|
2016
Q3 | $2.05M | Buy |
45,900
+39,300
| +595% | +$1.7M | ﹤0.01% | 3534 |
|
|
2016
Q2 | $252K | Sell |
6,600
-6,100
| -48% | -$268K | ﹤0.01% | 7246 |
|
|
2016
Q1 | $523K | Buy |
12,700
+6,800
| +115% | +$280K | ﹤0.01% | 6324 |
|
|
2015
Q4 | $286K | Sell |
5,900
-900
| -13% | -$40K | ﹤0.01% | 7780 |
|
|
2015
Q3 | $272K | Buy |
+6,800
| New | +$297K | ﹤0.01% | 8203 |
|
Other funds holding SYNH
IA
BTI
CFB
HNB
Susquehanna International Group's SYNH Position: Q3 2023 in Review
Susquehanna International Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 37,614 shares — an estimated $1.59M sold.
Susquehanna International Group first reported a position in SYNH in Q4 2014 and held it in 25 quarters. The position peaked at $5.02M in Q4 2016. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.
- Susquehanna International Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
- Susquehanna International Group sold 37,614 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $1.59M.
- Susquehanna International Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 25 quarters.
- Susquehanna International Group's Syneos Health, Inc. Class A Common Stock position peaked at $5.02M in Q4 2016.
- 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.
Based on Susquehanna International Group's 13F filing for Q3 2023, filed 14 Nov 2023.